90 related articles for article (PubMed ID: 15953675)
1. Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant.
Li Z; Ding Q; Li Y; Miller SA; Abbruzzese JL; Hung MC
Cancer Lett; 2006 May; 236(1):58-63. PubMed ID: 15953675
[TBL] [Abstract][Full Text] [Related]
2. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
Deharvengt S; Wack S; Aprahamian M; Hajri A
J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
5. Molecular target-based therapy of pancreatic cancer.
Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
[TBL] [Abstract][Full Text] [Related]
6. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
8. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice.
Sarkar D; Su ZZ; Vozhilla N; Park ES; Randolph A; Valerie K; Fisher PB
Cancer Res; 2005 Oct; 65(19):9056-63. PubMed ID: 16204080
[TBL] [Abstract][Full Text] [Related]
9. Systemic tumor suppression by the proapoptotic gene bik.
Zou Y; Peng H; Zhou B; Wen Y; Wang SC; Tsai EM; Hung MC
Cancer Res; 2002 Jan; 62(1):8-12. PubMed ID: 11782349
[TBL] [Abstract][Full Text] [Related]
10. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake.
Egami T; Ohuchida K; Mizumoto K; Onimaru M; Toma H; Nishio S; Nagai E; Matsumoto K; Nakamura T; Tanaka M
Clin Cancer Res; 2008 Mar; 14(6):1859-67. PubMed ID: 18347189
[TBL] [Abstract][Full Text] [Related]
11. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Bik antitumor effect by Bik mutants.
Li YM; Wen Y; Zhou BP; Kuo HP; Ding Q; Hung MC
Cancer Res; 2003 Nov; 63(22):7630-3. PubMed ID: 14633680
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
14. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
Lai RX; Zhang SN; Nakamura T; Yuan SZ
Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
[TBL] [Abstract][Full Text] [Related]
15. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
17. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Petrigliano FA; Virk MS; Liu N; Sugiyama O; Yu D; Lieberman JR
Prostate; 2009 Sep; 69(13):1422-34. PubMed ID: 19489029
[TBL] [Abstract][Full Text] [Related]
18. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
19. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
20. Efficient inhibition of ovarian cancer growth and prolonged survival by transfection with a novel pro-apoptotic gene, hPNAS-4, in a mouse model. In vivo and in vitro results.
Yang F; Li Z; Deng H; Yang H; Yan F; Qian Z; Chen L; Wei Y; Zhao X
Oncology; 2008; 75(3-4):137-44. PubMed ID: 18824876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
